Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
Condition(s):Primary AldosteronismLast Updated:December 11, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Primary AldosteronismLast Updated:December 11, 2023Not yet recruiting
Condition(s):Central Serous ChorioretinitisLast Updated:February 25, 2016Completed
Condition(s):Systolic Heart FailureLast Updated:February 1, 2023Enrolling by invitation
Condition(s):Hyperandrogenism; Polycystic Ovary Syndrome; PubertyLast Updated:October 27, 2023Recruiting
Condition(s):Respiratory Distress Syndrome, AdultLast Updated:October 28, 2021Completed
Condition(s):Cardiotoxicity; Neoplasms; Chemotherapy Effect; Heart FailureLast Updated:August 22, 2023Not yet recruiting
Condition(s):Atrial FibrillationLast Updated:June 5, 2008Unknown status
Condition(s):COVID-19; ARDSLast Updated:November 25, 2020Unknown status
Condition(s):NASH – Nonalcoholic SteatohepatitisLast Updated:July 7, 2023Completed
Condition(s):Heart Failure With Preserved Ejection FractionLast Updated:February 16, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.